Fibroid uterus cases with anemia in premenopausal women are more likely to have vitamin D deficiency as compared to cases without anemia, according to a study from India in the journal Cureus.
The hospital-based case-control study evaluated the association between serum ferritin and vitamin D levels.
The study was conducted in the Department of Biochemistry at All India Institute of Medical Sciences in Bhubaneswar, India.
In total, 60 clinically diagnosed premenopausal women with uterine fibroids (UFs), aged 25 to 45, who were attending the outpatient section of the hospital’s ob/gyn department were enrolled randomly: 30 women with anemia and 30 without anemia.
A peripheral blood smear, a complete blood count (CBC) and hemoglobin (Hb) were measured by a fully automated analyzer; serum ferritin levels were estimated by a three-site sandwich immunoassay using direct chemiluminometric technology in a chemiluminescence immunoassay analyzer; and 25(OH) vitamin D level was measured by an enzyme-linked immunosorbent assay (ELISA).
The 1-hour daily exposure to sunlight was moderate in all patients, thus eliminating the confounding effect of sunlight exposure influencing vitamin D levels.
In the anemic group, 28 patients had vitamin D deficiency and 2 were vitamin D insufficiency, compared to 19 patients in the control group who were vitamin D deficient, 9 with vitamin D insufficiency and 2 with vitamin D sufficiency.
A significant difference was found in ferritin levels between cases and control (P < 0.001). There was also a strong positive correlation between serum ferritin and vitamin D levels.
The median vitamin D level in cases was 5.0 ng/ml [interquartile range (IQR): 4.8], compared to 18.4 ng/ml (IQR: 7.9) in controls (P < 0.001).
In addition, 5 patients in the anemic group were found to have an iron deficiency state, all of whom had vitamin D deficiency.
The odds ratio with a 95% confidence interval (CI) between the serum vitamin D groups (vitamin D deficiency and vitamin D insufficiency) and serum ferritin groups (low and normal ferritin levels) was 9.6 (95% CI: 1.1 to 80.9 (P = .019).
“This indicates that low ferritin levels are associated with vitamin D deficiency in fibroid subjects,” wrote the authors.
Factors affecting vitamin D levels include female gender, winter season, lack of sunlight exposure, residence in high latitudes, dark skin, clothing with low exposure, obesity, low socioeconomic status, and malnutrition.
Serum ferritin and Hb levels were the 2 important factors impacting serum vitamin D values.
“Low serum vitamin D levels in fibroid cases could be due to the fact that vitamin D reduces the effect of transforming growth factor β3 (TGFβ3)-mediated expression of collagen type-1, and the expression and activity of metalloproteinase (MMP-2, MMP-9) that degrades the extracellular matrix,” wrote the authors.
The authors noted that vitamin D estimation in fibroid uterus cases with anemia would help better manage patients.
The strong positive correlation observed between serum ferritin and vitamin D levels indicates that fibroid uterus cases “with microcytic hypochromic anemia should also be evaluated for vitamin D deficiency, as timely corrective measures would improve the treatment outcomes in women with fibroid uterus,” concluded the authors.
__
Reference
Pap Talk S4E4: RFA and uterine fibroids with Dr. Jessica Shepherd
March 30th 2022In this episode of Pap Talk, Jessica Shepherd, MD, MBA, FACOG, deep dives into the benefits of utilizing radio frequency ablation (RFA) for treatment of uterine fibroids, available RFA devices, and disparities in the condition.
Listen
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Physician-patient collaboration for uterine fibroid treatment options
May 12th 2021Contemporary OB/GYN®’s senior editor Angie DeRosa sat down with Ayman Al-Hendy, MD, and Sateria Venable of The Fibroid Foundation, to discuss the role of patient-physician collaboration in uterine fibroid treatment and management options.
Listen
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More